Targeting β-tubulin:CCT-β complexes incurs Hsp90- and VCP-related protein degradation and induces ER stress-associated apoptosis by triggering capacitative Ca2+ entry, mitochondrial perturbation and caspase overactivation.
Targeting β-tubulin:CCT-β complexes incurs Hsp90- and VCP-related protein degradation and induces ER stress-associated apoptosis by triggering capacitative Ca2+ entry, mitochondrial perturbation and caspase overactivation.
复制标题
DOI:
10.1038/cddis.2012.173
复制
发表时间:
2012-11-29
影响因子:
9
通讯作者:
Liang, P-H
中科院分区:
文献类型:
--
作者:
Lin, Y-F;Lee, Y-F;Liang, P-H
We have previously demonstrated that interrupting the protein–protein interaction (PPI) of β-tubulin:chaperonin-containing TCP-1β (CCT-β) induces the selective killing of multidrug-resistant cancer cells due to CCT-β overexpression. However, the molecular mechanism has not yet been identified. In this study, we found that CCT-β interacts with a myriad of intracellular proteins involved in the cellular functions of the endoplasmic reticulum (ER), mitochondria, cytoskeleton, proteasome and apoptosome. Our data show that the targeted cells activate both the heat-shock protein 90 (Hsp90)-associated protein ubiquitination/degradation pathway to eliminate misfolded proteins in the cytoplasm and the valosin-containing protein (VCP)-centered ER-associated protein degradation pathway to reduce the excessive levels of unfolded polypeptides from the ER, thereby mitigating ER stress, at the onset of β-tubulin:CCT-β complex disruption. Once ER stress is expanded, ER stress-associated apoptotic signaling is enforced, as exhibited by cellular vacuolization and intracellular Ca2+ release. Furthermore, the elevated intracellular Ca2+ levels resulting from capacitative Ca2+ entry augments apoptotic signaling by provoking mitochondrial perturbation and caspase overactivation in the targeted cells. These findings not only provide a detailed picture of the apoptotic signaling cascades evoked by targeting the β-tubulin:CCT-β complex but also demonstrate a strategy to combat malignancies with chemoresistance to Hsp90- and VCP-related anticancer agents.
登录
查看更多内容
影响因子:
8.8
作者:
Cameron, EM;Zhuang, J;Fink, MP
通讯作者:
Fink, MP
影响因子:
2.8
作者:
DAHLMANN, B;KUEHN, L
通讯作者:
KUEHN, L
影响因子:
11.2
作者:
Lin, Yuan-Feng;Tsai, Wen-Ping;Liang, Po-Huang
通讯作者:
Liang, Po-Huang
影响因子:
3.5
作者:
Kim, Hyung-Ryong;Kim, Myung-Sunny;Chae, Han-Jung
通讯作者:
Chae, Han-Jung
影响因子:
4.8
作者:
Pearce, Margaret M. P.;Wormer, Duncan B.;Wojcikiewicz, Richard J. H.
通讯作者:
Wojcikiewicz, Richard J. H.